Product Code: GVR-4-68040-081-2
Health Check-up Market Growth & Trends
The global health check-up market size is expected to reach USD 73.67 billion by 2030, expanding at a CAGR of 5.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market growth is attributable to the increasing awareness about general health among people, rising investments from government & non-government bodies, and the adoption of technologically advanced testing products across various healthcare platforms. For instance, in March 2021, F. Hoffmann-La Roche Ltd launched a connected blood glucose monitoring system under the Accu-Chek Instant System brand name. The connected system enables integrated and personalized diabetes management, to establish active care and communication between patient and healthcare provider.
The increasing geriatric population across the economies is driving the demand for health check-ups, as elderly patients are more susceptible to chronic illnesses and require preventive healthcare. For instance, according to an article published by the WHO in October 2022, it is estimated that 1 in 6 people across the world will be aged above 60 by 2030. Hence, regulatory support to provide preventive care to the geriatric population will drive the health check-up industry. For example, the U.N. Decade of Healthy Ageing (2021-2030) aims to improve the elder population's lives by implementing four frameworks, such as delivering primary health services and dedicated care to the senior population.
The growing deficiency of vitamins in the population drives the market for testing and monitoring. For instance, according to the National Institute of Health Database research published in October 2021, in the U.S., approximately 42% of the population is vitamin deficient. In addition, Frontiers Media S.A. published an article on February 2023, estimating that the global prevalence of vitamin deficiency from 2000 to 2022 was 15.7%, while the prevalence is anticipated to increase due to a sedentary lifestyle and low sunlight exposure. However, global medical device companies have continued to launch products to detect vitamin D levels at home and seek connected healthcare aid, driving the global health check-up industry. For instance, in April 2022, MediSure Labs launched the first Health Canada-approved Vitamin D home testing kit in the Canadian region.
Moreover, key players operating in the global health check-up industry are focusing on strategic initiatives, such as product launches to increase their respective position in the marketplace. For instance, in January 2023, Burning Rock received breakthrough device designation from the U.S. FDA for its OverC Multi-Cancer detection blood test. The test helps in the early detection of esophageal, ovarian, pancreatic, liver, and lung cancer in adults aged 50-75 years. Furthermore, in February 2023, Dexcom, Inc. launched G7 continuous glucose monitoring system for beneficiaries with type 1 and type 2 diabetes, and the product will be covered by Medicare. Hence, the launch of next-generation testing products will allow the global health check-up industry to grow during the forecast period.
Health Check-up Market Report Highlights
- The general health check-up segment held the largest revenue share in 2022 and is attributable to the high use of testing services to identify critical medical issues
- The blood glucose test segment held the largest share in 2022, owing to the high prevalence of diabetes and rapid growth in the geriatric population
- The cardiovascular diseases segment dominated the market in 2022 owing to the high prevalence of diseases coupled with high mortality rates and technological advancements in testing products
- Hospital-based laboratories held the largest revenue share in 2022 owing to the increasing number of hospitals integrating laboratories and a large patient pool
- Individuals segment of the market capture the largest revenue share in 2022 due to increasing awareness about preventive health check-ups along with the introduction of connected medical devices from market players
- North America region led the market in 2022, which can be attributed to the high access to healthcare insurance along with an increase in the prevalence of non-communicable diseases
- The key market players include Quest Diagnostics Incorporated; Laboratory Corporation of America Holdings; SYNLAB International GmbH; Eurofins Scientific; UNILABS; Sonic Healthcare Limited; Q2 Solutions; LalPathLabs.com; and ARUP Laboratories.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation and Scope
- 1.1.1 Segment Definations
- 1.1.1.1 Type segment
- 1.1.1.2 Test type segment
- 1.1.1.3 Application segment
- 1.1.1.4 Service provider segment
- 1.1.1.5 End-use segment
- 1.2 Regional Scope
- 1.3 Estimates and Forecast Timeline
- 1.4 Objectives
- 1.4.1 Objective - 1
- 1.4.2 Objective - 2
- 1.4.3 Objective - 3
- 1.5 Research Methodology
- 1.6 Information Procurement
- 1.6.1 Purchased Database
- 1.6.2 Gvr's Internal Database
- 1.6.3 Secondary Sources
- 1.6.4 Primary Research
- 1.7 Information Or Data Analysis
- 1.7.1 Data Analysis Models
- 1.8 Market Formulation & Validation
- 1.9 Model Details
- 1.9.1 Commodity Flow Analysis
- 1.10 List of Secondary Sources
- 1.11 List of Abbreviations
Chapter 2 Executive Summary
- 2.1 Market Snapshot
- 2.2 Test and Test Type Segment Snapshot
- 2.3 Application and Service Provider Segment Snapshot
- 2.4 End-Use Segment Snapshot
- 2.5 Competitive Landscape Snapshot
Chapter 3 Health Check-Up Market Variables, Trends, and Scope
- 3.1 Market Lineage Outlook
- 3.2 Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.1.1 Increasing Prevalence Of Diseases
- 3.2.1.2 Growing Investments In Population Screening
- 3.2.1.3 Growing Geriatric Population
- 3.2.1.4 Adoption Of Digital Technology
- 3.2.2 Market Restraint Analysis
- 3.2.2.1 High Cost Associated With Screening
- 3.2.2.2 Psychological Factors And Knowledge, Attitudes, & Beliefs
- 3.2.3 Challenges
- 3.2.3.1 Lack Of Awareness
- 3.2.4 Opportunity
- 3.2.4.1 Rising Medical Tourism
- 3.3 Current & Future Market Opportunity Analysis
- 3.4 Business Environment Analysis Tools
- 3.4.1 Porter's Five Forces Analysis
- 3.4.2 Pestle Analysis
- 3.5 Impact of COVID-19: Qualitative Analysis
Chapter 4 Health Check-Up Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)
- 4.1 Health Check-Up Market: Type Movement Analysis
- 4.2 Health Check-Up Market Estimates & Forecast, By Type (USD Million)
- 4.2.1 General Health Check-Up
- 4.2.2 Preventive Health Check-Up
- 4.2.3 Specialized Health Check-Up
- 4.2.4 Routine & Wellness Check-Up
Chapter 5 Health Check-Up Market - Segment Analysis, By Test Type, 2018 - 2030 (USD Million)
- 5.1 Health Check-Up Market: Test Type Movement Analysis
- 5.2 Health Check-Up Market Estimates & Forecast, By Test Type (USD Million)
- 5.2.1 Blood Glucose Tests
- 5.2.2 Kidney Function Tests
- 5.2.3 Bone Profile
- 5.2.4 Electrolytes
- 5.2.5 Liver Function Tests
- 5.2.6 Lipid Profile
- 5.2.7 Special Biochemistry
- 5.2.8 Cardiac Biomarkers
- 5.2.9 Hormones & Vitamins
- 5.2.10 Tumor Markers
- 5.2.11 Others
Chapter 6 Health Check-Up Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)
- 6.1 Health Check-Up Market: Application Movement Analysis
- 6.2 Health Check-Up Market Estimates & Forecast, By Application (USD Million)
- 6.2.1 Cardiovascular Diseases
- 6.2.2 Metabolic Disorders
- 6.2.3 Cancer
- 6.2.4 Inflammatory Conditions
- 6.2.5 Musculoskeletal Disorders
- 6.2.6 Neurological Conditions
- 6.2.7 Others
Chapter 7 Health Check-Up Market - Segment Analysis, by Service Provider, 2018 - 2030 (USD Million)
- 7.1 Health Check-Up Market: Service Provider Movement Analysis
- 7.2 Health Check-Up Market Estimates & Forecast, By Service Provider (USD Million)
- 7.2.1 Hospital-Based Laboratories
- 7.2.2 Central Laboratories
- 7.2.3 Standalone Laboratories
Chapter 8 Health Check-Up Market - Segment Analysis, By End-Use, 2018 - 2030 (USD Million)
- 8.1 Health Check-Up Market: End-Use Movement Analysis
- 8.2 Health Check-Up Market Estimates & Forecast, By End-Use (USD Million)
- 8.2.1 Enterprise
- 8.2.2 Individuals
Chapter 9 Health Check-Up Market: Regional Estimates and Trend Analysis, by Type, Test Type, Service Provider, Application, & End-Use
- 9.1 Health Check-Up Market: Regional Outlook
- 9.2 North America
- 9.2.1 North America Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.2.2 U.S.
- 9.2.2.1 Key Country Dynamics
- 9.2.2.2 U.S. Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.2.2.3 Target Disease Prevalence
- 9.2.2.4 Competitive Scenario
- 9.2.2.5 Regulatory Framework
- 9.2.2.6 Reimbursement Scenario
- 9.2.3 Canada
- 9.2.3.1 Key Country Dynamics
- 9.2.3.2 Canada Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.2.3.3 Target Disease Prevalence
- 9.2.3.4 Competitive Scenario
- 9.2.3.5 Regulatory Framework
- 9.2.3.6 Reimbursement Scenario
- 9.3 Europe
- 9.3.1 Europe Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.3.2 Uk
- 9.3.2.1 Key Country Dynamics
- 9.3.2.2 Uk Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.3.2.3 Target Disease Prevalence
- 9.3.2.4 Competitive Scenario
- 9.3.2.5 Regulatory Framework
- 9.3.2.6 Reimbursement Scenario
- 9.3.3 Germany
- 9.3.3.1 Key Country Dynamics
- 9.3.3.2 Germany Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.3.3.3 Target Disease Prevalence
- 9.3.3.4 Competitive Scenario
- 9.3.3.5 Regulatory Framework
- 9.3.3.6 Reimbursement Scenario
- 9.3.4 France
- 9.3.4.1 Key Country Dynamics
- 9.3.4.2 France Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.3.4.3 Target Disease Prevalence
- 9.3.4.4 Competitive Scenario
- 9.3.4.5 Regulatory Framework
- 9.3.4.6 Reimbursement Scenario
- 9.3.5 Spain
- 9.3.5.1 Key Country Dynamics
- 9.3.5.2 Spain Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.3.5.3 Target Disease Prevalence
- 9.3.5.4 Competitive Scenario
- 9.3.5.5 Regulatory Framework
- 9.3.5.6 Reimbursement Scenario
- 9.3.6 Italy
- 9.3.6.1 Key Country Dynamics
- 9.3.6.2 Italy Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.3.6.3 Target Disease Prevalence
- 9.3.6.4 Competitive Scenario
- 9.3.6.5 Regulatory Framework
- 9.3.6.6 Reimbursement Scenario
- 9.3.7 Denmark
- 9.3.7.1 Key Country Dynamics
- 9.3.7.2 Denmark Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.3.7.3 Target Disease Prevalence
- 9.3.7.4 Competitive Scenario
- 9.3.7.5 Regulatory Framework
- 9.3.7.6 Reimbursement Scenario
- 9.3.8 Sweden
- 9.3.8.1 Key Country Dynamics
- 9.3.8.2 Sweden Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.3.8.3 Target Disease Prevalence
- 9.3.8.4 Competitive Scenario
- 9.3.8.5 Regulatory Framework
- 9.3.8.6 Reimbursement Scenario
- 9.3.9 Norway
- 9.3.9.1 Key Country Dynamics
- 9.3.9.2 Italy Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.3.9.3 Target Disease Prevalence
- 9.3.9.4 Competitive Scenario
- 9.3.9.5 Regulatory Framework
- 9.3.9.6 Reimbursement Scenario
- 9.4 Asia Pacific
- 9.4.1 Asia Pacific Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.2 Japan
- 9.4.2.1 Key Country Dynamics
- 9.4.2.2 Japan Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.2.3 Target Disease Prevalence
- 9.4.2.4 Competitive Scenario
- 9.4.2.5 Regulatory Framework
- 9.4.2.6 Reimbursement Scenario
- 9.4.3 China
- 9.4.3.1 Key Country Dynamics
- 9.4.3.2 China Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.3.3 Target Disease Prevalence
- 9.4.3.4 Competitive Scenario
- 9.4.3.5 Regulatory Framework
- 9.4.3.6 Reimbursement Scenario
- 9.4.4 India
- 9.4.4.1 Key Country Dynamics
- 9.4.4.2 India Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.4.3 Target Disease Prevalence
- 9.4.4.4 Competitive Scenario
- 9.4.4.5 Regulatory Framework
- 9.4.4.6 Reimbursement Scenario
- 9.4.5 South Korea
- 9.4.5.1 Key Country Dynamics
- 9.4.5.2 South Korea Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.5.3 Target Disease Prevalence
- 9.4.5.4 Competitive Scenario
- 9.4.5.5 Regulatory Framework
- 9.4.5.6 Reimbursement Scenario
- 9.4.6 Australia
- 9.4.6.1 Key Country Dynamics
- 9.4.6.2 Australia Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.6.3 Target Disease Prevalence
- 9.4.6.4 Competitive Scenario
- 9.4.6.5 Regulatory Framework
- 9.4.6.6 Reimbursement Scenario
- 9.4.7 Thailand
- 9.4.7.1 Key Country Dynamics
- 9.4.7.2 Thailand Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.7.3 Target Disease Prevalence
- 9.4.7.4 Competitive Scenario
- 9.4.7.5 Regulatory Framework
- 9.4.7.6 Reimbursement Scenario
- 9.5 Latin America
- 9.5.1 Latin America Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.2 Brazil
- 9.5.2.1 Key Country Dynamics
- 9.5.2.2 Brazil Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.2.3 Target Disease Prevalence
- 9.5.2.4 Competitive Scenario
- 9.5.2.5 Regulatory Framework
- 9.5.2.6 Reimbursement Scenario
- 9.5.3 Mexico
- 9.5.3.1 Key Country Dynamics
- 9.5.3.2 Mexico Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.3.3 Target Disease Prevalence
- 9.5.3.4 Competitive Scenario
- 9.5.3.5 Regulatory Framework
- 9.5.3.6 Reimbursement Scenario
- 9.5.4 Argentina
- 9.5.4.1 Key Country Dynamics
- 9.5.4.2 Argentina Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.4.3 Target Disease Prevalence
- 9.5.4.4 Competitive Scenario
- 9.5.4.5 Regulatory Framework
- 9.5.4.6 Reimbursement Scenario
- 9.6 Mea
- 9.6.1 Mea Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.2 South Africa
- 9.6.2.1 Key Country Dynamics
- 9.6.2.2 South Africa Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.2.3 Target Disease Prevalence
- 9.6.2.4 Competitive Scenario
- 9.6.2.5 Regulatory Framework
- 9.6.2.6 Reimbursement Scenario
- 9.6.3 Saudi Arabia
- 9.6.3.1 Key Country Dynamics
- 9.6.3.2 Saudi Arabia Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.3.3 Target Disease Prevalence
- 9.6.3.4 Competitive Scenario
- 9.6.3.5 Regulatory Framework
- 9.6.3.6 Reimbursement Scenario
- 9.6.4 Uae
- 9.6.4.1 Key Country Dynamics
- 9.6.4.2 Uae Health Check-Up Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.4.3 Target Disease Prevalence
- 9.6.4.4 Competitive Scenario
- 9.6.4.5 Regulatory Framework
- 9.6.4.6 Reimbursement Scenario
- 9.6.5 Kuwait
- 9.6.5.1 Key Country Dynamics
- 9.6.5.2 Kuwait Health Check-Up Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.5.3 Target Disease Prevalence
- 9.6.5.4 Competitive Scenario
- 9.6.5.5 Regulatory Framework
- 9.6.5.6 Reimbursement Scenario
Chapter 10 Competitive Landscape
- 10.1 Company Categorization
- 10.2 Strategy Mapping
- 10.2.1 New Product Launch
- 10.2.2 Partnerships
- 10.2.3 Acquisition
- 10.2.4 Collaboration
- 10.2.5 Funding
- 10.3 Key Company Market Share Analysis, 2022
- 10.4 Company Profiles
- 10.4.1 Quest Diagnostics Incorporated
- 10.4.1.1 Company Overview
- 10.4.1.2 Financial Performance
- 10.4.1.3 Product Benchmarking
- 10.4.1.4 Strategic Initiatives
- 10.4.2 Laboratory Corporation Of America Holdings
- 10.4.2.1 Company Overview
- 10.4.2.2 Financial Performance
- 10.4.2.3 Product Benchmarking
- 10.4.2.4 Strategic Initiatives
- 10.4.3 Synlab International Gmbh
- 10.4.3.1 Company Overview
- 10.4.3.2 Financial Performance
- 10.4.3.3 Product Benchmarking
- 10.4.3.4 Strategic Initiatives
- 10.4.4 Bioreference Health, Llc
- 10.4.4.1 Company Overview
- 10.4.4.2 Financial Performance
- 10.4.4.3 Product Benchmarking
- 10.4.4.4 Strategic Initiatives
- 10.4.5 Eurofins Scientific
- 10.4.5.1 Company Overview
- 10.4.5.2 Financial Performance
- 10.4.5.3 Product Benchmarking
- 10.4.5.4 Strategic Initiatives
- 10.4.6 Sonic Healthcare Limited
- 10.4.6.1 Company Overview
- 10.4.6.2 Financial Performance
- 10.4.6.3 Product Benchmarking
- 10.4.6.4 Strategic Initiatives
- 10.4.7 Arup Laboratories
- 10.4.7.1 Company Overview
- 10.4.7.2 Financial Performance
- 10.4.7.3 Product Benchmarking
- 10.4.7.4 Strategic Initiatives
- 10.4.8 Q2 Solutions
- 10.4.8.1 Company Overview
- 10.4.8.2 Financial Performance
- 10.4.8.3 Product Benchmarking
- 10.4.8.4 Strategic Initiatives
- 10.4.9 Unilabs
- 10.4.9.1 Company Overview
- 10.4.9.2 Financial Performance
- 10.4.9.3 Product Benchmarking
- 10.4.9.4 Strategic Initiatives
- 10.4.10 Lalpathlabs.Com
- 10.4.10.1 Company Overview
- 10.4.10.2 Financial Performance
- 10.4.10.3 Product Benchmarking
- 10.4.10.4 Strategic Initiatives
Chapter 11 Conclusion